reducing cases of the disease.
The hope is they will multiply, breed and become the majority of mosquitoes, thus reducing cases of the disease.
The initiative is part of a programme also taking place in Australia, Vietnam and Indonesia.
The intercellular bacteria, Wolbachia, being introduced cannot be transmitted to humans.
The programme started in 2012 says Luciano Moreira of the Brazilian research institute Fiocruz, who is leading the project in Brazil .
"Our teams performed weekly visits to the four neighbourhoods in Rio being targeted. Mosquitoes were analysed after collection in special traps.
"Transparency and proper information for the households is priority. "
Ten thousands mosquitoes will be released each month for four months with the first release in Tubiacanga, in the north of Rio.
The bacteria Wolbachia is found in 60% of insects. It acts like a vaccine for the mosquito which carries Dengue, Aedes Aegypti, stopping the Dengue virus multiplying in its body.
Wolbachia also has an effect on reproduction. If a contaminated male fertilises the eggs of a female without the bacteria, these eggs do not turn into larvae.
If the male and female are contaminated or if only a female has the bacteria, all future generations of mosquito will carry Wolbachia.
As a result, Aedes mosquitoes with Wolbachia become predominant without researchers having to constantly release more contaminated insects.
In Australia this happened within 10 weeks on average.
The research on Wolbachia began at the University of Monash in Australia in 2008. The researchers allowed the mosquitoes to feed on their own arms for five years because of concerns at the time Wolbachia could infect humans and domestic animals.
Three more neighbourhoods will be targeted next, and large scale studies to evaluate the effect of the strategy are planned for 2016.
CommentairesAucun commentaire pour le moment
Suivre le flux RSS des commentaires
Ajouter un commentaire